Anika Therapeutics (AKP) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

0 Followers

Earnings Data

Report Date

Nov 06, 2026

After Close (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

0.35

Last Year’s EPS

0.03

Same Quarter Last Year

Moderate Buy

Based on 2 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:AKP Upcoming Earnings

Anika Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2026	2026 (Q3)	0.35 / -	0.033	―	―	―
Jul 29, 2026	2026 (Q2)	0.02 / 0.35	-0.107	423.08% (+0.45)
Apr 29, 2026	2026 (Q1)	0.00 / 0.22	-0.049	550.00% (+0.27)
Feb 26, 2026	2025 (Q4)	-0.10 / 0.26	-0.025	1133.33% (+0.28)
Nov 05, 2025	2025 (Q3)	-0.15 / 0.03	-0.206	116.00% (+0.24)
Jul 30, 2025	2025 (Q2)	-0.22 / -0.11	0.14	-176.47% (-0.25)
May 09, 2025	2025 (Q1)	-0.07 / -0.05	0.074	-166.67% (-0.12)
Mar 12, 2025	2024 (Q4)	-0.19 / -0.02	0.041	-160.00% (-0.07)
Oct 31, 2024	2024 (Q3)	0.07 / -0.21	0	―
Aug 08, 2024	2024 (Q2)	0.06 / 0.14	0.049	183.33% (+0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Anika Therapeutics (CH:AKP) report earnings?

Anika Therapeutics (CH:AKP) is schdueled to report earning on Nov 06, 2026, After Close (Confirmed).

What is Anika Therapeutics (CH:AKP) earnings time?

Anika Therapeutics (CH:AKP) earnings time is at Nov 06, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Anika Therapeutics stock?

The P/E ratio of Anika Therapeutics is N/A.

What is CH:AKP EPS forecast?

CH:AKP EPS forecast for the fiscal quarter 2026 (Q3) is 0.35.